Chronic Alcohol Use Disorder: Causes, Health Effects, and Treatment

Chronic alcohol use disorder (AUD)—formerly termed chronic ethanolism or alcoholism—is a medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. It exists on a spectrum from mild to severe.

Causes and Risk Factors

AUD arises from a complex interplay of factors:

  • Genetic: Heritability ~50–60%; variants in ADH1B, ALDH2, GABRA2, and others affect metabolism and reward sensitivity.
  • Neurobiological: Alcohol hijacks the mesolimbic dopamine system (reward), enhances GABAergic inhibition, and suppresses glutamatergic excitation. Chronic use leads to neuroadaptation (tolerance, dependence).
  • Psychological: Comorbid anxiety, depression, PTSD, or trauma; drinking to cope (self-medication).
  • Environmental: Early initiation, peer/family drinking culture, stress, availability, marketing.

Health Consequences

SystemEffects
LiverSteatosis, alcoholic hepatitis, fibrosis, cirrhosis, hepatocellular carcinoma
CardiovascularHypertension, cardiomyopathy, arrhythmias (atrial fibrillation), stroke
NeurologicalWernicke-Korsakoff syndrome, peripheral neuropathy, cerebellar atrophy, cognitive impairment, dementia
GI/PancreasGastritis, pancreatitis, Mallory-Weiss tears, esophageal varices, malabsorption
OncologicOropharyngeal, esophageal, liver, colorectal, breast cancer
PsychiatricDepression, anxiety, insomnia, increased suicide risk
SocialRelationship loss, unemployment, legal issues, financial ruin

Treatment

Evidence-based, multimodal approach:

  1. Medications (FDA-approved): Naltrexone (reduces craving/pleasure), acamprosate (restores glutamate/GABA balance), disulfiram (aversive reaction). Others used off-label: topiramate, gabapentin, baclofen.
  2. Behavioral therapies: Cognitive-behavioral therapy (CBT), motivational enhancement therapy (MET), contingency management, 12-step facilitation (AA), mindfulness-based relapse prevention.
  3. Support systems: Mutual-help groups (AA, SMART Recovery), peer recovery coaches, sober living.
  4. Medical management: Detoxification (benzodiazepines for withdrawal seizure prophylaxis), nutritional repletion (thiamine, folate, magnesium), treatment of comorbidities.

Prognosis

Remission is achievable. ~1/3 achieve stable abstinence; another 1/3 have significant reduction in heavy drinking; relapse is common but not failure—it informs treatment adjustment. Early intervention improves outcomes.

Drug Addiction - Related Articles